evaluation of Niosomal Erythromycin in the Treatment of Acne Vulgaris
Not Applicable
- Conditions
- acne.
- Registration Number
- IRCT2017101035524N3
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
The inclusion criteria were those with mild to moderate acne vulgaris and 12-35 years old.
The exclusion criteria were as follows: pregnant or lactating women, people with known hypersensitivity to erythromycin and zinc acetate, treatment with oral isotretinoin within last 6 months, oral estrogen compounds within last 3 months, topical retinoid compounds and antibiotics within last 1 month, patients with hirsutism, androgenetic alopecia and polycystic ovary syndrome.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of inflammatory,non-inflammatory acne lesions,quality of life before and after the treatment. Timepoint: 2,4,8,12 weeks. Method of measurement: counting of the inflammatory,noninflammatory and total acne lesions,assessment of quality of life by Cardiff acne disability index ( CADI.
- Secondary Outcome Measures
Name Time Method Adverse effects(erythema,burning and itching sensation,peeling). Timepoint: 2,4,8,12 weeks. Method of measurement: by question of patients and physical examination.